Press "Enter" to skip to content

Randomized phase III study of ganetespib, a heat shock protein 90 inhibitor, with docetaxel vs docetaxel in advanced non–small-cell lung cancer (GALAXY-2) – MD Linx

admin 0

Randomized phase III study of ganetespib, a heat shock protein 90 inhibitor, with docetaxel vs docetaxel in advanced non–small-cell lung cancer (GALAXY-2)  MD Linx
“lung cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *